• Meropenem Trihydrate in Antibiotic Resistance & Diagnostics

  2026-04-22

  Meropenem trihydrate stands out as a gold-standard carbapenem antibiotic for probing resistance mechanisms, especially in rapid LC-MS/MS metabolomics workflows. See how this compound enables reproducible, high-impact research in both acute necrotizing pancreatitis models and cutting-edge diagnostics for carbapenemase-producing Enterobacterales.

• FLAG tag Peptide: Precision in Recombinant Protein Detection

  2026-04-22

  The FLAG tag Peptide (DYKDDDDK) streamlines protein purification and detection, empowering researchers with high solubility, enterokinase-cleavage, and reliable affinity resin compatibility. Explore workflow enhancements, troubleshooting strategies, and translational insights—anchored by the latest mechanistic evidence and APExBIO’s rigorous quality.

• Topotecan (SKU B4982): Advanced Strategies for Pediatric Tum

  2026-04-21

  Explore the unique potential of Topotecan in pediatric solid tumor models and apoptosis induction in glioma cells. This in-depth article offers advanced insights and practical guidance for cancer research, highlighting APExBIO’s Topotecan beyond standard assay optimization.

• BMN 673 (Talazoparib): Mechanism, Evidence, and Research Uti

  2026-04-21

  BMN 673 (Talazoparib) is a highly potent, selective PARP1/2 inhibitor that demonstrates superior DNA repair deficiency targeting in cancer research. Its efficacy, molecular mechanism, and protocol parameters are quantitatively defined, supporting reproducibility in homologous recombination deficient cancer models.

• Angiotensin Peptides Enhance SARS-CoV-2 Spike–AXL Binding

  2026-04-20

  This study demonstrates that naturally occurring angiotensin peptides, including Angiotensin (1-7), can enhance the binding of the SARS-CoV-2 spike protein to the AXL receptor. These findings provide new insight into peptide-mediated modulation of viral entry and may inform the design of antiviral and translational research workflows.

• Antimycin A4: Advanced ATP-Citrate Lyase Inhibitor Workflows

  2026-04-20

  Antimycin A4 empowers precision control of mitochondrial energy pathways and lipid biosynthesis in cell-based assays. Its dual inhibition profile enables researchers to dissect metabolic dependencies and troubleshoot complex workflows, setting a new standard for ATP-citrate lyase inhibitor applications.

• Cycloheximide as a Protein Biosynthesis Inhibitor: Workflows

  2026-04-19

  Cycloheximide empowers researchers to dissect protein turnover, apoptosis, and translational control with high temporal precision. This guide translates bench-proven workflows and recent mechanistic advances—including sunitinib resistance in renal cell carcinoma—into actionable protocols for advanced cell biology.

• Homoharringtonine: Cytotoxic Alkaloid for Cancer & SARS-CoV-

  2026-04-18

  Homoharringtonine is a cytotoxic alkaloid that inhibits protein synthesis by targeting the eukaryotic 80S ribosome. It induces cell cycle arrest in leukemic cells and demonstrates potent antiviral activity against SARS-CoV-2, supporting its use in cancer biology and antiviral research. The compound is supplied by APExBIO under SKU N1504.

• CX-5461: Workflow Optimization for RNA Polymerase I Inhibiti

  2026-04-17

  Leverage CX-5461, a potent RNA polymerase I inhibitor, to dissect ribosome biogenesis and overcome chemoresistance in solid tumor research. This guide details experimental workflows, troubleshooting strategies, and advanced use-cases, drawing on the latest mechanistic insights and reference protocols.

• Caspase-4 Colorimetric Assay: Bridging Mechanism and Impact

  2026-04-16

  Explore how precision measurement of caspase-4 activity is reshaping translational research in inflammatory cell death. This thought-leadership article integrates mechanistic insight, strategic assay deployment, and cross-domain perspectives—culminating in a vision for next-generation cell fate modulation.

• Biotin-16-UTP: Precision RNA Labeling for Interaction Studie

  2026-04-15

  Biotin-16-UTP streamlines sensitive RNA-protein interaction assays and RNA purification by enabling robust, site-specific biotin labeling during in vitro transcription. Learn how optimized protocols and troubleshooting strategies can maximize reproducibility and specificity in advanced RNA research workflows.

• Amyloid Beta-peptide (25-35): Applied Models for Neurotoxici

  2026-04-14

  Amyloid Beta-peptide (25-35) (Aβ25-35) is the gold standard for modeling Alzheimer's disease neurotoxicity, supporting reproducible workflows from microglial polarization to drug screening. This article delivers actionable protocols, troubleshooting guidance, and key insights from the latest research, empowering advanced neurodegenerative disease studies.

• Omeprazole (A2845): Practical Guide for Gastric Acid Researc

  2026-04-13

  Omeprazole (SKU A2845) is a potent H+,K+-ATPase inhibitor designed for controlled studies of gastric acid secretion and antiulcer mechanisms. This compound is intended for research workflows modeling peptic ulcer disease or evaluating proton pump inhibition. It should not be applied in diagnostic, therapeutic, or non-gastric research settings without clear, product-supported rationale.

• Pazopanib Hydrochloride: Translational Guidance for Oncology

  2026-04-13

  This thought-leadership article blends mechanistic insights and strategic advice for translational researchers leveraging Pazopanib Hydrochloride (GW786034) in anti-angiogenic cancer research. It dissects the compound's multi-target inhibition profile, integrates best practices for in vitro evaluation, benchmarks against the competitive landscape, and offers a forward-looking perspective on bridging laboratory findings with clinical application. Anchored in recent systems biology findings and practical workflow guidance, it distinguishes itself as a strategic resource beyond typical product summaries.

• Quercetin Modulates Hippo Signaling to Protect Cataract Lens

  2026-04-12

  This study identifies quercetin as a modulator of the Hippo signaling pathway in cataract models, linking pathway inactivation to decreased lens opacity and improved epithelial cell survival. The findings highlight a mechanistic basis for non-surgical cataract intervention strategies focused on pathway-targeted modulation.

14766 records 1/985 page Next 12345 下5页 Last page